What is the main business of TOP Pharm Jargan-Szklorz?

The main business activity of TOP Pharm Jargan-Szklorz focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 17, 2014.

Where is the headquarters located?

The headquarters is located at: 3 Maja 13, 41-200 Sosnowiec.

What is the legal form?

The legal form of this entity is a general partnership (sp.j.).

What period do the latest financial data cover?

The latest available financial statement covers the period from July 1, 2023 to June 30, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $4,436,061, representing a decrease of 32.4% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $425,138, meaning the company decreased its profit by 50.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $3,127,574 in 2024, representing 78% of all operating expenses.

Top Pharm Jargan-Szklorzsp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-02-17

Registered address

3 Maja 13, 41-200 Sosnowiec, Poland

Electronic delivery address

AE:PL-57194-97816-REEUD-26

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 83 days late).

2025not filed
202410/10/2024
202313/10/2023
202106/10/2022
202015/07/2021
201911/09/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Dispensing chemist in specialised stores530 / 1,847

Top 29%

Division · Retail trade2,562 / 13,245

Top 19%

Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles7,981 / 42,241

Top 19%

Voivodeship · Śląskie4,940 / 51,325

Top 9.6%

Country · Poland47,734 / 495,860

Top 9.6%

Results vs industry

Revenue

This companyUSD 4.44mMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD 425.14kMedianUSD 20.70kAverageUSD 86.94k

Operating costs

This companyUSD 4.01mMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 902.73kMedianUSD 543.65kAverageUSD 1.76m

Industry

National Health Fund (NFZ) contracts

Top Pharm Jargan-Szklorz has been an NFZ healthcare provider since 2014. In 2026 it is performing 8 contracts with a total value of USD 1.50k. All its contracts were worth USD 5.50k in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Pilot programmes	śląskie	2	USD 1.18k
Pilot programmes	małopolskie	1	USD 324.15
Provision of medical devices	śląskie	1	USD 0.00
Provision of medical devices	małopolskie	1	USD 0.00
Other services provided in pharmacies	małopolskie	1	USD 0.00

Authorized Representatives

Agata Jargan Barańska – Attorney-in-fact (sole)

Katarzyna Danuta Szklorz – Attorney-in-fact (sole)

Jolanta Izabela Jargan – Attorney-in-fact (sole)

Marta Szklorz Papierniak – Attorney-in-fact (sole)

Manner of representation

Each partner independently.

Ownership

Owner
Indra Bis sp. z o.o.
Indra Sp. z o.o.
Jolanta Izabela Jargan
Leszek Piotr Jarganage 64
Agata Joanna Jargan Barańska
Andrzej Roman Szklorzage 64
Katarzyna Danuta Szklorz
Marta Patrycja Szklorz Papierniak

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2014-02-20.

Alior Bank
97 2490 0005 0000 4600 1875 8480
Alior Bank
14 2490 0005 0000 4530 9544 3950

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,223$4,223	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,952$4,952	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,558$4,558	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Dolnośląska Grupa AptecznaS.A.	$30,168,188.68	dgasa.pl
Management CompanyS.A.	$18,905,980.22	managementcompany.pl
Modrzewscysp. j.	$5,602,358.99	aptekacentrum.lublin.pl
Ms-Pharmsp. z o.o. + limited partnership	$4,619,501.46	mspharm.pl
Farmjug Agsp. z o.o.	$4,213,734.86	farmjug.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Adpharmasp. z o.o.	$4,026,799.19	adamed.com
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.	$3,414,382.70	aptekazielona.com.pl
Herbarium Świętego Franciszkasp. z o.o.	$1,397,577.12	herbarium.katowice.pl
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A.	–	farmacol.com.pl